@conference {41321,
	title = {The dairy product value chain: new opportunities from a holistic approach?},
	booktitle = {Proceedings of the New Zealand Society of Animal Production},
	volume = {62},
	year = {2002},
	month = {Jan},
	pages = {86-89},
	publisher = {New Zealand Society of Animal Production},
	organization = {New Zealand Society of Animal Production},
	address = {Palmerston North},
	abstract = {The value chain for dairy products extends from on-farm production, through manufacturing and distribution, to the final consumer.  Using an integrated approach across the value chain, it is possible to produce products that better suit consumers{\textquoteright} needs or preferences and that return more value to the farmer using on-farm methods.  This approach requires a change in mindset for the manufacturing industry, and can be successful only in an industry that is fully integrated from cowshed to consumer. Some examples are described in the context of the value chain, and set the  framework for the following papers.},
	issn = {1176-5283},
	author = {Boland MJ}
}
@conference {41327,
	title = {Milk and consumer health: review of the evidence for a relationship between the consumption of beta-casein A1 with heart disease and insulin-dependent diabetes mellitus},
	booktitle = {Proceedings of the New Zealand Society of Animal Production},
	volume = {62},
	year = {2002},
	month = {Jan},
	pages = {111-114},
	publisher = {New Zealand Society of Animal Production},
	organization = {New Zealand Society of Animal Production},
	address = {Palmerston North},
	abstract = {New developments in dairy foods, identifying health benefits from "functional foods" have a counterpart in claims of adverse health effects from milk components. A prime example is the present highly publicised claim of adverse effects of "A1 milk". Although there is some evidence that the consumption of beta-casein A1 may have an effect on the development of insulin dependent diabetes, other studies in this area have produced results that are inconsistent with such a claim. Some studies indicate that the removal of beta-casein A1 from the diet would have no influence on the incidence of insulin dependent diabetes. Epidemiological evidence for a relationship between the consumption of milk (and of beta-casein A1) with heart disease appears to have been a serendipitous correlation that occurred in the past perhaps due to a common underlying factor) but now no longer holds. Elimination of beta-casein A1 from the diet will have no effect on the mortality rate due to heart disease. Evidence to support claims that the consumption of the A1 variant of the milk protein beta-casein is a causative factor in heart disease and insulin dependent diabetes is therefore not sufficient to promote a change in consumer milk consumption away from dairy products containing beta-casein A1. },
	issn = {1176-5283},
	author = {Hill JP and Crawford RA and Boland MJ}
}
